University Of Maryland, Baltimore
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
Duloxetine for Treatment of Painful Temporomandibular Joint Disorder
Not Applicable
Completed
- Conditions
- Temporomandibular Joint Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2021-05-25
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 24
- Registration Number
- NCT00981149
- Locations
- 🇺🇸
University of Maryland Dental School, Baltimore, Maryland, United States
Tacrolimus to Sirolimus Conversion for Delayed Graft Function
Phase 4
Terminated
- Conditions
- Kidney TransplantDelayed Graft Function
- Interventions
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 32
- Registration Number
- NCT00931255
- Locations
- 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2019-09-26
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 31
- Registration Number
- NCT00925119
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Salt Loading and Thiazide Intervention Study
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- Procedure: Salt loading
- First Posted Date
- 2009-05-11
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 124
- Registration Number
- NCT00896389
- Locations
- 🇺🇸
Amish Research Clinics, Lancaster, Pennsylvania, United States
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
Phase 2
Terminated
- Conditions
- Alcohol AbuseAlcoholism
- Interventions
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 74
- Registration Number
- NCT00890149
- Locations
- 🇺🇸
Clinical Neurobehavioral Center, Columbia, Maryland, United States
Oxytocin and Social Cognition in Schizophrenia
Phase 2
Completed
- Conditions
- Social CognitionSocial AnxietyEmotional Intelligence
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-04-21
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 28
- Registration Number
- NCT00884897
- Locations
- 🇺🇸
Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP), Catonsville, Maryland, United States
Med-alert Bracelet in Chronic Kidney Disease
Completed
- Conditions
- Chronic Kidney Disease
- Interventions
- Device: Medical Alert Bracelet
- First Posted Date
- 2009-04-17
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 26
- Registration Number
- NCT00883389
Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
Completed
- Conditions
- CardiomyopathyChronic Kidney DiseaseAnemia
- First Posted Date
- 2009-04-17
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 20
- Registration Number
- NCT00883415
- Locations
- 🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States
Mindfulness Intervention For Child Abuse Survivors (MICAS)
Not Applicable
Completed
- Conditions
- Child Abuse Survivors
- Interventions
- Behavioral: Mindfulness-Based Stress Reduction program
- First Posted Date
- 2009-03-24
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 20
- Registration Number
- NCT00867802
- Locations
- 🇺🇸
Kernan Hospital, Baltimore, Maryland, United States
Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
Phase 2
Terminated
- Conditions
- Shigella
- Interventions
- Biological: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 20
- Registration Number
- NCT00866242
- Locations
- 🇺🇸
University of Maryland, Baltimore Center for Vaccine Development, Baltimore, Maryland, United States
🇺🇸Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath